Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-26 @ 2:35 AM
Study NCT ID:
NCT05066802
Status:
UNKNOWN
Last Update Posted:
2021-10-04
First Post:
2021-09-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma
Sponsor:
Yonsei University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-23
First Submit QC Date:
None
Study First Post Date:
2021-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-23
Last Update Post Date:
2021-10-04
Last Update Post Date Type:
ACTUAL